a16z show• Mar 9, 2026• 50:50Interview

Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

From a16z show

Andrew Huberman•Neuroscientist and Podcaster

Executive Summary

The COVID-19 pandemic accelerated a major shift towards consumer-driven health, with individuals becoming more proactive in managing their own wellness through supplements, fitness, and self-education.
There is a booming gray and black market for peptides and GLP-1 drugs used for weight loss, performance enhancement, and cognitive focus, highlighting a gap between consumer demand and regulated access.
Andrew Huberman is highly bullish on transformative technologies like mRNA cancer vaccines and predicts that GLP-1 drugs will be taken by over half of Americans within five years for a range of indications.
The next frontier in health technology will move beyond passively 'reading' biological data (e.g., sleep trackers) to actively 'writing' to biological systems to induce desired states, such as sleep or enhanced performance.

11 quotes

Concerns Raised

Risks associated with unregulated gray and black market peptides and drugs.
Overuse of stimulants for focus and the negative long-term health consequences.
Misinformation and political polarization hindering scientific progress, such as mRNA vaccine funding.
The slow pace of traditional pharma and regulation compared to consumer demand.

Opportunities Identified

The massive market for GLP-1 drugs for weight loss, addiction, and cognitive benefits.
Development of new technologies that can 'write' to biological systems to improve health.
The potential of mRNA vaccines to treat cancer.
Creating safer, non-stimulant alternatives for cognitive enhancement.

Key Themes

The Consumer Health Revolution

The pandemic catalyzed a fundamental shift where individuals became more proactive and self-directed in managing their health, moving beyond traditional medicine. This is driven by a desire for control, access to information, and a growing skepticism of institutions.

This trend creates massive opportunities for companies in supplements, wearables, health information, and personalized medicine, but also raises concerns about misinformation and the safety of unregulated practices.

The Rise of Peptides and GLP-1s

There's an explosion in the use of peptides and GLP-1 drugs for a wide range of applications, from weight loss and injury repair to cognitive enhancement and anti-aging. Much of this activity occurs in unregulated 'gray' and 'black' markets.

This highlights a significant gap between consumer demand for performance-enhancing compounds and the pace of FDA approval, creating both market opportunities and substantial public health risks.

Bio-Hacking for Cognitive and Physical Performance

The conversation details the widespread use of various substances, from FDA-approved drugs like Sunosi to gray-market peptides, to enhance focus, alertness, and physical capabilities. Huberman notes the high demand but also the inherent risks, such as sleep disruption and cardiovascular strain.

This points to a large, unmet need for safe and effective cognitive and physical enhancers, representing a major frontier for biotech and pharmaceutical development.

From Reading to Writing Biology

Huberman outlines the next frontier in health tech: moving from simply monitoring biological signals (e.g., sleep trackers) to actively influencing or 'writing' to biological systems. Examples include targeted cooling to induce sleep or mRNA vaccines reprogramming the immune system.

This conceptual shift from passive monitoring to active intervention signals a new paradigm for therapeutic and wellness technologies, with profound implications for treating disease and optimizing human performance.

Get started free

Topics

Peptides GLP-1 Bio-hacking Cognitive Enhancement Stimulants mRNA Vaccines Cancer Treatment Health Technology Consumer Health Self-Care Circadian Rhythms Sleep Optimization Neuroscience Compounding Pharmacies FDA Regulation

Processed Apr 9, 2026 yt-dlp + mlx-whisper + Gemini